Small Cap Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 15, 2025

Discover small cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ADXN Addex Therapeutics	CHF 0.05	-7.4%	-71.4%	CHF 4.9m	n/a	PS8.3x	E18.5%	n/a
RLF Relief Therapeutics Holding	CHF 2.47	20.2%	96.0%	CHF 31.0m	n/a	PS3.7x	n/a	n/a
CURN Curatis Holding	CHF 10.75	-0.5%	n/a	CHF 53.7m	CHF 84.50	n/a	n/a	n/a
XLS Xlife Sciences	CHF 19.00	-4.5%	-47.2%	CHF 109.1m	n/a	PE5.1x	n/a	n/a
MOLN Molecular Partners	CHF 3.25	1.2%	-3.8%	CHF 119.8m	CHF 10.50	PS24.1x	E-7.0%	n/a
NWRN Newron Pharmaceuticals	CHF 6.64	-5.0%	-8.0%	CHF 132.5m	CHF 17.62	PE9x	E42.2%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 13.96	6.1%	53.6%	CHF 175.8m	CHF 25.00	PE2.8x	S-76.7%	n/a
BIOV BioVersys	CHF 34.00	-5.6%	n/a	CHF 196.4m	CHF 60.00	n/a	n/a	n/a
IDIA Idorsia	CHF 1.11	14.8%	-48.5%	CHF 248.5m	CHF 1.00	PS2.2x	E51.1%	n/a
BSLN Basilea Pharmaceutica	CHF 41.70	2.0%	1.5%	CHF 505.8m	CHF 77.28	PE6.5x	E-10.1%	0%
PPGN PolyPeptide Group	CHF 15.42	1.0%	-46.6%	CHF 508.8m	CHF 29.85	PS1.6x	E64.4%	0%
COPN Cosmo Pharmaceuticals	CHF 48.30	-0.8%	-31.5%	CHF 773.5m	CHF 103.37	PE6.3x	E-51.1%	3.9%
KURN Kuros Biosciences	CHF 22.16	23.3%	202.7%	CHF 841.2m	n/a	PS11.1x	n/a	n/a
SKAN SKAN Group	CHF 63.30	2.4%	-23.4%	CHF 1.4b	CHF 90.67	PE36.7x	E16.3%	0.6%
TECN Tecan Group	CHF 146.70	0.6%	-56.5%	CHF 1.9b	CHF 250.29	PE27.6x	E17.2%	2.0%
DESN Dottikon ES Holding	CHF 183.40	2.7%	-20.9%	CHF 2.5b	CHF 350.00	PE33.6x	S16.4%	0%
BANB Bachem Holding	CHF 48.34	3.5%	-39.5%	CHF 3.6b	CHF 70.71	PE30.1x	E15.8%	1.8%
SFZN Siegfried Holding	CHF 885.00	5.7%	-0.1%	CHF 3.9b	CHF 1,146.09	PE24.2x	E9.7%	0.4%
SDZ Sandoz Group	CHF 33.43	1.1%	19.7%	CHF 14.4b	CHF 42.43	PS1.7x	E29.8%	1.7%
GALD Galderma Group	CHF 79.70	-0.6%	26.9%	CHF 18.9b	CHF 104.80	PE99.5x	E30.4%	n/a
LONN Lonza Group	CHF 540.60	3.7%	2.7%	CHF 38.2b	CHF 656.71	PE60x	E21.1%	0.7%
NOVN Novartis	CHF 90.20	1.8%	6.1%	CHF 171.2b	CHF 96.06	PE17.4x	E7.2%	3.5%
ROG Roche Holding	CHF 255.40	2.2%	15.3%	CHF 204.7b	CHF 313.38	PE24.5x	E14.3%	3.8%